Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis

Published:2016-03-15 Issue:6 Volume:59 Page:2362-2380
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Karabanovich Galina¹,Zemanová Júlia²,Smutný Tomáš¹,Székely Rita³,Šarkan Michal²,Centárová Ivana²,Vocat Anthony³,Pávková Ivona⁴,Čonka Patrik¹,Němeček Jan¹,Stolaříková Jiřina⁵,Vejsová Marcela¹,Vávrová Kateřina¹,Klimešová Věra¹,Hrabálek Alexandr¹,Pávek Petr¹,Cole Stewart T.³,Mikušová Katarína²,Roh Jaroslav¹

Affiliation:

1. Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 50005 Hradec Králové, Czech Republic

2. Faculty of Natural Sciences, Department of Biochemistry, Comenius University in Bratislava, Mlynská dolina, Ilkovičova 6, 842 15 Bratislava, Slovakia

3. Ecole Polytechnique Fédérale de Lausanne, Global Health Institute, CH-1015 Lausanne, Switzerland

4. Faculty of Military Health Sciences, Department of Molecular Pathology and Biology, University of Defence, Třebešská 1575, 50005 Hradec Králové, Czech Republic

5. Department of Bacteriology and Mycology, Regional Institute of Public Health, Partyzánské náměstí 7, 70200 Ostrava, Czech Republic

Funder

Ministerstva Školství, Mládeže A Telovýchovy

Czech Science Foundation

Univerzita Karlova

European Social Fund

Seventh Framework Programme

Agentúra na Podporu Výskumu a Vývoja

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine